Kinase inhibitors as therapeutic agents

A compound or pharmaceutically acceptable salts thereof of Formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.

Saved in:
Bibliographic Details
Main Authors GORDON THOMAS D, SALMERON-GARCIA JOSE-ANDRES, FRIEDMAN MICHAEL, WISHART NEIL, BISCHOFF AGNIEZKA K, TALANIAN ROBERT V, ROTH GREGORY P, WALLACE GRIER A, THOMAS CHRISTINE, ALLEN HAMISH J, CUSACK KEVIN, GEORGE DAWN M, BARBERIS CLAUDE E, YU ZHENGTIAN, ERICSSON ANNA
Format Patent
LanguageEnglish
Published 06.04.2006
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract A compound or pharmaceutically acceptable salts thereof of Formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
AbstractList A compound or pharmaceutically acceptable salts thereof of Formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
Author TALANIAN ROBERT V
THOMAS CHRISTINE
GEORGE DAWN M
BARBERIS CLAUDE E
ALLEN HAMISH J
GORDON THOMAS D
SALMERON-GARCIA JOSE-ANDRES
WISHART NEIL
CUSACK KEVIN
YU ZHENGTIAN
WALLACE GRIER A
FRIEDMAN MICHAEL
BISCHOFF AGNIEZKA K
ERICSSON ANNA
ROTH GREGORY P
Author_xml – fullname: GORDON THOMAS D
– fullname: SALMERON-GARCIA JOSE-ANDRES
– fullname: FRIEDMAN MICHAEL
– fullname: WISHART NEIL
– fullname: BISCHOFF AGNIEZKA K
– fullname: TALANIAN ROBERT V
– fullname: ROTH GREGORY P
– fullname: WALLACE GRIER A
– fullname: THOMAS CHRISTINE
– fullname: ALLEN HAMISH J
– fullname: CUSACK KEVIN
– fullname: GEORGE DAWN M
– fullname: BARBERIS CLAUDE E
– fullname: YU ZHENGTIAN
– fullname: ERICSSON ANNA
BookMark eNrjYmDJy89L5WRQ987MSyxOVcjMy8hMyizJLypWSCxWKMlILUosSC0tyUxWSExPzSsp5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgYGZgbmJoYGRo6GxsSpAgA-3Cq2
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2006074102A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2006074102A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:57:17 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2006074102A13
Notes Application Number: US20050129624
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060406&DB=EPODOC&CC=US&NR=2006074102A1
ParticipantIDs epo_espacenet_US2006074102A1
PublicationCentury 2000
PublicationDate 20060406
PublicationDateYYYYMMDD 2006-04-06
PublicationDate_xml – month: 04
  year: 2006
  text: 20060406
  day: 06
PublicationDecade 2000
PublicationYear 2006
Score 2.6417975
Snippet A compound or pharmaceutically acceptable salts thereof of Formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Kinase inhibitors as therapeutic agents
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060406&DB=EPODOC&locale=&CC=US&NR=2006074102A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTVNMgfW5Ba6pmYmibomqSZmupZJJia6yaCLbZMsjNOSwUcp-fqZeYSaeEWYRjAx5MD2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1eO8YmCbN1FycbF0D_F38ndWcnW1Dg9X8giBywNrTwMgR2FdiBTakzUH5wTXMCbQvpQC5UnETZGALAJqXVyLEwJSaJ8zA6Qy7e02YgcMXOuUNZEJzX7EIg7p3Zh6w0lHIzMvITMoEXZOjkFisgLSDSiERtFGqWJRB2c01xNlDF2hjPNyD8aHByM4zFmNgAXb9UyUYFJITQV3I5KTENGA1bGySnGiUDGwAmaeZJaWlAnsiFpIMMvhMksIvLc3ABRlQMNE1MJNhYCkpKk2VBVaxJUly4JABACZ3fgs
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsXp1IJSn4pjTT98KOL6QXVrN1wreytNaLEgddiK_76X7MM-7S0kcPkgl9_9ktwdwJ2mUQOR3FQ0naQKyYiuPFJCFMYT21JTzZkIpRSEuh-T14W2aMHnxhdGxAn9FcERUaMY6nstzuvl_yWWI_5WVg-0wKqvJy-yHHnLjnFP6rIzstzZ1Jnasm1b8VwO31ZtiJ6D4TNypT00sg2uD-77iPulLJug4h3B_gzllfUxtLKyCx17k3utCwfB-skbi2vtq07gflyUCDpSUX4UtOBpcqS0khoeVFLKHaWqU7j13Mj2Fewx2U4wiefN4aln0Ebqn52DxFJOIRlNc4RhlbB0yNAAMnKd5hkyEbMH_V2SLnY330DHj4JJMnkJx5dwuLpcIMpA70O7_v7JrhBua3otVukPOrWA_g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Kinase+inhibitors+as+therapeutic+agents&rft.inventor=GORDON+THOMAS+D&rft.inventor=SALMERON-GARCIA+JOSE-ANDRES&rft.inventor=FRIEDMAN+MICHAEL&rft.inventor=WISHART+NEIL&rft.inventor=BISCHOFF+AGNIEZKA+K&rft.inventor=TALANIAN+ROBERT+V&rft.inventor=ROTH+GREGORY+P&rft.inventor=WALLACE+GRIER+A&rft.inventor=THOMAS+CHRISTINE&rft.inventor=ALLEN+HAMISH+J&rft.inventor=CUSACK+KEVIN&rft.inventor=GEORGE+DAWN+M&rft.inventor=BARBERIS+CLAUDE+E&rft.inventor=YU+ZHENGTIAN&rft.inventor=ERICSSON+ANNA&rft.date=2006-04-06&rft.externalDBID=A1&rft.externalDocID=US2006074102A1